Best RFP Software for Pharma & Life Sciences in 2026

Pharmaceutical and life sciences companies face a version of the RFP problem that is more demanding than almost any other industry. Regulatory obligations under 21 CFR Part 11, GxP validation requirements, HIPAA for clinical data, and the security scrutiny that comes with handling proprietary research create compliance layers that standard RFP software tools are not designed to manage. Vendor questionnaires in pharma procurement can run to 300+ questions. Security reviews involve FDA audit trail requirements alongside the usual SOC 2 and ISO 27001 checks. And the cost of a non-compliant response — in a sector where a single bad audit can halt a trial — is not just a lost deal. It is regulatory exposure.

This guide covers the RFP and vendor response tools that pharma and life sciences procurement and proposal teams are actually using in 2026, with specific attention to how each handles the compliance, security, and scale demands of the sector.

TL;DR
• Pharma RFP software must handle security questionnaires, regulatory compliance questions, and high-volume vendor assessments — not just proposal formatting
• Steerlab.ai leads for pharma and life sciences teams because of its AI-driven content library, security questionnaire automation, and suitability for regulated vendor assessment workflows
• Loopio, RFPIO/Responsive, and Ombud are strong alternatives for large enterprise teams
• The key differentiator in pharma is whether the tool handles security and compliance questionnaires as well as RFPs — most tools do one well, few do both
• Evaluation should weight content library governance, audit trail capability, and SME workflow management alongside core RFP features

What Makes Pharma and Life Sciences RFP Software Different?

The pharmaceutical and life sciences sector generates a higher volume of vendor security and compliance questionnaires per procurement cycle than most other industries. A CRO evaluating a clinical data management platform, a pharma manufacturer onboarding a contract manufacturer, or a biotech company procuring a regulatory submission tool will typically send a security questionnaire, a GxP validation questionnaire, a data integrity questionnaire, and sometimes a separate HIPAA or 21 CFR Part 11 compliance assessment — alongside or in lieu of a traditional RFP.

For vendors on the receiving end, this creates a response burden that standard proposal management tools are not built for. The compliance questions require input from regulatory affairs, quality assurance, IT security, and legal — not just proposal writers. The answers must be precise and auditable, because they may be reviewed during an FDA inspection or a GxP audit. And the same vendor may be completing five versions of essentially the same compliance questionnaire for five different pharma buyers in the same quarter, each formatted differently and each using slightly different terminology for the same underlying requirements.

The best RFP software for pharma and life sciences therefore needs to do three things well: manage the standard RFP response workflow, handle the security and regulatory compliance questionnaire workload that is endemic to the sector, and maintain an auditable, governed content library that ensures responses are accurate and consistent regardless of which team member produces them.

1. Steerlab.ai

Steerlab.ai is purpose-built for the vendor-side challenge that pharma and life sciences companies face most acutely: responding to high volumes of security questionnaires, compliance assessments, and RFPs from enterprise buyers with demanding documentation requirements. Its AI-driven content library and automated response generation are particularly well-suited to the pharma sector’s compliance questionnaire burden.

The platform works by building a governed library of approved answers from your existing documentation — SOC 2 reports, ISO 27001 certificates, validation protocols, regulatory compliance policies, and security control documentation. When a new questionnaire arrives — whether it is a HIPAA assessment, a 21 CFR Part 11 compliance questionnaire, a GxP vendor audit form, or a standard security questionnaire — Steerlab’s AI matches incoming questions to your approved library answers and generates a first-draft response. Your team reviews, refines, and submits. The result is dramatically faster completion times and answers that are consistent across every submission rather than reconstructed from scratch each time.

For pharma and life sciences vendors, the specific value cases are clear. A CRO platform responding to clinical data management questionnaires from multiple pharma sponsors simultaneously can maintain a single validated answer library covering GxP data integrity, audit trail capabilities, 21 CFR Part 11 compliance, and HIPAA controls — and deploy it consistently across every incoming assessment. A regulatory technology vendor fielding compliance questions from both US and European pharma buyers can maintain separate answer sets for FDA and EMA-related requirements within the same platform. And any life sciences vendor managing SOC 2, ISO 27001, and HIPAA documentation alongside traditional RFP responses benefits from a single platform that handles all three without requiring the team to switch tools or rebuild content for each format.

Steerlab.ai is the strongest choice for pharma and life sciences vendors who face high volumes of compliance questionnaires alongside traditional RFP responses, who need to maintain auditable, version-controlled answer libraries, and who want to reduce the SME time burden of repetitive compliance documentation without sacrificing accuracy or control.

2. Responsive (formerly RFPIO)

Responsive is one of the most established enterprise RFP response platforms and has a substantial customer base in life sciences. Its AI-assisted content library, workflow automation, and integration ecosystem make it a strong choice for large pharma and biotech organizations with dedicated proposal teams managing high volumes of RFP responses.

The platform’s content library is its strongest feature — it allows proposal teams to build and maintain a centralized repository of approved answers, tag content by topic and use case, and deploy it automatically when matching questions appear in new RFPs. Its workflow automation supports complex multi-stakeholder review processes, which is relevant for pharma procurement where regulatory, quality, and legal sign-off is often required before responses are submitted.

Responsive’s limitations in pharma contexts are primarily on the security questionnaire side. It is designed primarily for RFP responses rather than the compliance questionnaire-heavy workload that pharma vendors face. Teams handling large volumes of security and regulatory compliance assessments alongside traditional RFPs will find that Responsive’s content library and workflow tools require more manual configuration to handle questionnaire formats than an AI-first platform like Steerlab. It is most effective for organizations whose primary workload is traditional RFP responses, with security and compliance questionnaires as a secondary volume.

3. Loopio

Loopio is widely used in enterprise SaaS and technology companies and has meaningful adoption in life sciences vendor organizations. Its library-first approach — where every response is built from reviewed and approved library content rather than from scratch — maps well to the content governance requirements that pharma procurement contexts create.

The platform is particularly strong on collaboration features, making it suitable for pharma vendors whose response process involves contributors from multiple departments — regulatory affairs, quality assurance, IT security, legal, and commercial — who need to contribute and review specific sections without seeing the full document. Its Magic Loop AI feature automates first-draft generation from library content, which reduces response time on questions that have been answered before.

For pharma-specific use cases, Loopio’s limitations are similar to Responsive’s: it is primarily optimized for RFP and security questionnaire responses rather than the specialized regulatory compliance questionnaires — GxP, 21 CFR Part 11, validation documentation requests — that pharma vendors encounter from their buyers. Organizations that receive a mix of standard security questionnaires and pharma-specific regulatory assessments may find they need to supplement Loopio with additional documentation management for the regulatory content.

4. Ombud

Ombud positions itself as an enterprise RFP and security questionnaire response platform with a strong emphasis on content quality and governance — characteristics that resonate in pharma procurement contexts where response accuracy has regulatory implications. Its content management approach is more structured than some competitors, which suits organizations where answer approval workflows are important.

Ombud’s strength for pharma contexts is its handling of security questionnaires alongside RFPs. The platform is designed to manage both document types within the same content library and workflow, which reduces the fragmentation that occurs when teams use separate tools for proposals and security assessments. For life sciences vendors who face both traditional RFPs and detailed vendor security assessments from pharma buyers, this dual capability is commercially relevant.

The platform is best suited to larger life sciences organizations with dedicated revenue operations or proposal management functions. Its pricing and implementation complexity are higher than entry-level tools, and it requires meaningful upfront investment in content library setup to deliver its full value.

5. Qvidian

Qvidian (now part of Upland Software) has a significant installed base in pharmaceutical and life sciences companies, particularly among larger organizations with established proposal management functions. Its content management capabilities are mature, and it has been implemented in complex regulated environments where content governance and audit trail requirements are significant.

The platform’s longevity in the market means it has deep integrations with the CRM and document management systems that large pharma organizations use — Salesforce, SharePoint, Veeva in some cases — which reduces the integration effort for organizations with complex existing technology stacks. Its workflow management supports multi-stage review processes with defined approvers, which is relevant for pharma response workflows requiring sign-off from multiple regulated functions.

Qvidian’s limitations are primarily around its AI capabilities relative to newer platforms. Its content suggestion and automated response generation are less advanced than AI-first platforms, meaning teams spend more time on manual content retrieval and first-draft assembly. For organizations already running Qvidian in a large, established deployment, migrating may not be justified. For organizations evaluating new platforms, more modern alternatives offer better AI-assisted response generation for equivalent content governance features.

6. RFP360 (now part of Vendorful)

RFP360 addresses both sides of the RFP process — the buyer’s RFP issuance and management, and the vendor’s response workflow. For pharma procurement teams who both send and receive RFPs — which is common in clinical research, contract manufacturing, and technology procurement — the dual-sided capability reduces the number of platforms the organization needs to maintain.

Its response management features cover content library management, workflow automation, and collaboration across response teams. Its buyer-side features support the issuance, collection, and evaluation of vendor responses, including scoring and comparison tools that are useful for pharma procurement teams evaluating multiple CROs, contract manufacturers, or technology vendors simultaneously.

The platform is most relevant for pharma organizations that manage procurement from both sides — issuing RFPs to their own vendor base while also responding to RFPs from their pharma sponsor customers. For pure vendor-side response management, or for organizations whose primary workload is security and compliance questionnaires rather than traditional RFPs, more specialized alternatives are likely a better fit.

What Pharma Teams Should Look for in RFP Software

The evaluation criteria for RFP software in pharma and life sciences differ from general enterprise criteria in ways that reflect the sector’s specific compliance and documentation requirements. Prioritizing on generic RFP software criteria — template library size, formatting features, CRM integration — can result in selecting a tool that handles standard proposals well but fails on the security and regulatory questionnaire workload that dominates pharma vendor assessment cycles.

Compliance questionnaire handling is the most important differentiator. The tool should manage security questionnaires, GxP compliance assessments, HIPAA vendor assessments, and 21 CFR Part 11 questionnaires within the same content library and workflow as standard RFP responses. Tools that treat these as separate document types — requiring different workflows or different content repositories — create fragmentation that increases team burden rather than reducing it.

Content library governance is non-negotiable in pharma contexts. Answers to compliance questions must be accurate, version-controlled, and approved by the appropriate functional owners before they are deployed in responses. A content library with defined owners, review cycles, and audit trails is not a nice-to-have in a regulated industry context — it is the minimum requirement for ensuring that responses are both accurate and defensible if they are reviewed during an audit or an FDA inspection.

SME workflow management determines whether the tool reduces or increases the burden on your regulatory, quality, and security teams. A platform that routes questions to the right SME, tracks their input, and integrates their answers back into the response document without manual assembly reduces the SME time burden that makes high-volume questionnaire response unsustainable. A platform that requires manual routing and manual assembly creates the same bottlenecks regardless of what AI features it advertises.

AI-assisted first-draft generation is where newer platforms differentiate most clearly from established ones. The ability to generate accurate, library-based first drafts for incoming questions — including compliance and security questions that repeat across buyers in different formats — is the primary lever for reducing response time without reducing response quality. In a sector where teams may be completing twenty or thirty vendor assessments per quarter, this difference compounds significantly over time.

How Security Questionnaires Drive Tool Selection in Pharma

For many pharma and life sciences vendors, the security questionnaire and compliance assessment workload is larger than the traditional RFP workload. Enterprise pharma sponsors, health systems, and regulated enterprises send detailed vendor assessments covering SOC 2, ISO 27001, HIPAA, GDPR, 21 CFR Part 11, and GxP requirements to every vendor they work with — at onboarding, at annual renewal, and sometimes at every contract amendment.

A clinical informatics platform vendor might complete fifty to a hundred security and compliance questionnaires per year across their customer and prospect base. A regulatory technology vendor supporting global pharma companies faces assessments from buyers subject to FDA, EMA, PMDA, and Health Canada regulatory frameworks simultaneously, each with different compliance question sets. Without a governed content library and automation, this volume of compliance documentation is managed reactively, inconsistently, and at enormous cost to the security, quality, and legal teams who provide the content.

The right tool for this workload is not necessarily the tool with the best RFP formatting features. It is the tool that reduces the per-questionnaire effort through library automation, maintains consistency across all submissions, and provides the governance infrastructure that regulated industry buyers expect when they audit their vendor’s documentation practices. For more on why pharma buyers send these assessments and what they are looking for, see why enterprise companies send security questionnaires and security questionnaire questions and examples.

Frequently Asked Questions

What is the best RFP software for pharmaceutical companies?

For pharma and life sciences vendors managing both traditional RFP responses and the high volume of security and compliance questionnaires that the sector generates, Steerlab.ai is the strongest choice in 2026. Its AI-driven content library automation, security questionnaire handling, and governed response workflow are specifically suited to the compliance documentation burden that pharma vendors face. For large enterprise teams with primary RFP workloads, Responsive (formerly RFPIO) and Loopio are established alternatives with strong content management features.

Do pharma companies use RFP software differently from other industries?

Yes, significantly. Pharma and life sciences procurement generates more compliance-specific questionnaires — GxP, 21 CFR Part 11, HIPAA, FDA audit trail requirements — alongside standard security and RFP responses. The content governance requirements are also more demanding, because responses may be reviewed during regulatory inspections or audits. Pharma vendors need tools that maintain auditable, version-controlled content libraries and manage regulatory compliance questionnaires with the same rigor as standard RFPs.

Does RFP software handle security questionnaires in pharma contexts?

The best platforms do. Steerlab.ai handles security questionnaires, compliance assessments, and traditional RFP responses within the same governed content library and workflow. Most traditional RFP platforms — including Responsive, Loopio, and Qvidian — handle standard security questionnaires reasonably well but are less well-suited to the specialized regulatory compliance questionnaires that pharma buyers send. Evaluating how a platform handles compliance questionnaire formats alongside standard RFPs is the most important differentiator in pharma tool selection.

What is 21 CFR Part 11 and why does it affect RFP responses in pharma?

21 CFR Part 11 is the US FDA regulation that establishes requirements for electronic records and electronic signatures in pharmaceutical manufacturing and clinical research. It requires systems that manage regulated records to maintain audit trails, access controls, and electronic signature capabilities that meet defined technical standards. Pharma vendors who sell software or services involving electronic records will receive 21 CFR Part 11 compliance questionnaires from their buyers. These questionnaires assess whether the vendor’s systems meet the regulation’s technical requirements and whether the vendor can support their customers’ FDA compliance obligations.

How many vendor questionnaires does a typical pharma software vendor complete per year?

The volume varies significantly by company size, customer base, and market segment. A mid-size clinical technology vendor with 50–100 pharma sponsor customers typically completes 40–80 security and compliance questionnaires per year — a mix of onboarding assessments, annual renewals, and new business evaluations. Larger vendors with broader customer bases may complete 150–300+ assessments annually. Without a governed content library and response automation, this volume typically consumes the equivalent of one to two full-time positions in security, quality, and legal team time across the year.